Cytiva Acquires Vanrx Pharmasystems to Complement Biomanufacturing Capacity Solutions.

MANews-(C)2009-2021

UK-based life sciences company Cytiva has acquired Canada-based aseptic-filling machine maker Vanrx Pharmasystems, expanding portfolio to support smaller manufacturing for personalised therapies, the company said.

Terms of the transaction were not disclosed.

From drug development, through drug substance and now into drug product, Cytiva can help biomanufacturers bring their therapies to patients faster.

Vanrx will enhance Cytiva FlexFactory platforms and KUBio modular facilities, to accelerate biomanufacturing Vanrx's flagship products.

...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT